The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
Open accessAbstract
Since the separation of Pseudallescheria boydii and P. apiosperma in 2010, limited data on species-specific susceptibility patterns of these and other species of Pseudallescheria and its anamorph Scedosporium have been reported. This study presents the antifungal susceptibility patterns of members affiliated with both entities. Clinical and environmental isolates ( n = 332) from a wide range of sources and origins were identified down to species level and tested according to CLSI M38-A2 against eight antifungal compounds. Whereas P. apiosperma (geometric mean MIC/minimal effective concentration [MEC] values of 0.9, 2.4, 7.4, 16.2, 0.2, 0.8, 1.5, and 6.8 μg/ml for voriconazole, posaconazole, isavuconazole, itraconazole, micafungin, anidulafungin, caspofungin, and amphotericin B, respectively) and P. boydii (geometric mean MIC/MEC values of 0.7, 1.3, 5.7, 13.8, 0.5, 1.4, 2.3, and 11.8 μg/ml for voriconazole, posaconazole, isavuconazole, itraconazole, micafungin, anidulafungin, caspofungin, and amphotericin B, respectively) had similar susceptibility patterns, those for S. aurantiacum , S. prolificans , and S. dehoogii were different from each other. Voriconazole was the only drug with significant activity against S. aurantiacum isolates. The MIC distributions of all drugs except voriconazole did not show a normal distribution and often showed two subpopulations, making a species-based prediction of antifungal susceptibility difficult. Therefore, antifungal susceptibility testing of all clinical isolates remains essential for targeted antifungal therapy. Voriconazole was the only compound with low MIC values (MIC 90 of ≤2 μg/ml) for P. apiosperma and P. boydii . Micafungin and posaconazole showed moderate activity against the majority of Scedosporium strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Infections due to emerging and uncommon medically important fungal pathogens
Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., & Anaissie, E. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00839.x · Cited by 601
WALSH, T. J., LUTSAR, I., DRISCOLL, T., DUPONT, B., RODEN, M., GHAHRAMANI, P., HODGES, M., GROLL, A. H., & PERFECT, J. R. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00015 · Cited by 431
Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens
Purkins, L., Wood, N., Ghahramani, P., Greenhalgh, K., Allen, M. J., & Kleinermans, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2546-2553.2002 · Cited by 415
Husain, S., Munoz, P., Forrest, G., Alexander, B. D., Somani, J., Brennan, K., Wagener, M. M., & Singh, N. (2005) · Clinical Infectious Diseases · doi:10.1086/426445 · Cited by 401
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
Roffey, S. J., Cole, S., Comby, P., Gibson, D., Jezequel, S. G., Nedderman, A. N. R., Smith, D. A., Walker, D. K., & Wood, N. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.731 · Cited by 330
Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New Species
Gilgado, F., Cano, J., Gené, J., & Guarro, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.4930-4942.2005 · Cited by 298
Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*
Guarro, J., Kantarcioglu, A. S., Horré, R., Luis Rodriguez-Tudela, J., Cuenca Estrella, M., Berenguer, J., & Sybren De Hoog, G. (2006) · Medical Mycology · doi:10.1080/13693780600752507 · Cited by 297
Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients
Troke, P., Aguirrebengoa, K., Arteaga, C., Ellis, D., Heath, C. H., Lutsar, I., Rovira, M., Nguyen, Q., Slavin, M., & Chen, S. C. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-07 · Cited by 294
Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi
Brandt, M. E., & Warnock, D. W. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.supplement-2.36 · Cited by 287
Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis
Cimon, B., Carrère, J., Vinatier, J. F., Chazalette, J. P., Chabasse, D., & Bouchara, J. P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050011 · Cited by 271
Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases
Rodriguez-Tudela, J. L., Rodriguez-Tudela, J. L., Berenguer, J., Guarro, J., Kantarcioglu, A. S., Horre, R., Sybren De Hoog, G., & Cuenca-Estrella, M. (2009) · Medical Mycology · doi:10.1080/13693780802524506 · Cited by 269
Voriconazole in the treatment of fungal eye infections: a review of current literature
Hariprasad, S. M., Mieler, W. F., Lin, T. K., Sponsel, W. E., & Graybill, J. R. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.136515 · Cited by 263
Lutsar, I., Roffey, S., & Troke, P. (2003) · Clinical Infectious Diseases · doi:10.1086/377131 · Cited by 262
In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Rodriquez-Tudela, J. L., Donnelly, J. P., Verweij, P. E., & the EUROFUNG Network (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.62-68.2002 · Cited by 233
Self-citationGilgado, F., Cano, J., Gené, J., Sutton, D. A., & Guarro, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01122-07 · Cited by 228
Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
Rodriguez-Tudela, J. L., Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Monzon, A., & Cuenca-Estrella, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00156-08 · Cited by 209
Howden, B. P., Slavin, M. A., Schwarer, A. P., & Mijch, A. M. (2003) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0877-z · Cited by 198
Hope, W. W., Mickiene, D., Petraitis, V., Petraitiene, R., Kelaher, A. M., Hughes, J. E., Cotton, M. P., Bacher, J., Keirns, J. J., Buell, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524063 · Cited by 183
Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006
Lamaris, G. A., Chamilos, G., Lewis, R. E., Safdar, A., Raad, I. I., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/509579 · Cited by 163
Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex
Gilgado, F., Serena, C., Cano, J., Gené, J., & Guarro, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00981-06 · Cited by 159
Groll, A. H., Mickiene, D., Petraitis, V., Petraitienė, R., Ibrahim, K. H., Piscitelli, S. C., Bekersky, I., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3322-3327.2001 · Cited by 128
Heath, C. H., Slavin, M. A., Sorrell, T. C., Handke, R., Harun, A. B., Phillips, M. R., Nguyen, Q. A., Delhaès, L., Ellis, D., Meyer, W., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02802.x · Cited by 123
Symoens, F., Knoop, C., Schrooyen, M., Denis, O., Estenne, M., NOLARD, N., & Jacobs, F. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.12.011 · Cited by 113
Meletiadis, J., Mouton, J. W., Rodrı́guez-Tudela, J. L., Meis, J. F. G. M., & Verweij, P. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.470-472.2000 · Cited by 109
Self-citationSteinbach, W. J., Schell, W. A., Miller, J. L., & Perfect, J. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3981-3985.2003 · Cited by 105
Bhat, S. V., Paterson, D. L., Rinaldi, M. G., & Veldkamp, P. J. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600786564 · Cited by 100
Cuenca‐Estrella, M., Alastruey‐Izquierdo, A., Alcázar‐Fuoli, L., Bernal‐Martínez, L., Gómez‐López, A., Buitrago, M. J., Mellado, E., & Rodríguez-Tudela, J. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01160-07 · Cited by 88
Gosbell, I. B., Toumasatos, V., Yong, J., Kuo, R.-S., Ellis, D., & Perrie, R. C. (2003) · Mycoses (Berlin) · doi:10.1046/j.1439-0507.2003.00878.x · Cited by 85
de Valk, H. A., Meis, J. F. G. M., Pauw, B. E. D., Donnelly, P. J., & Klaassen, C. H. W. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02423-06 · Cited by 73
Self-citationA review of GermanScedosporium prolificanscases from 1993 to 2007
Tintelnot, K., Just‐Nübling, G., Horré, R., Graf, B., Sobottka, I., Seibold, M., Haas, A. V., Kaben, U., & de Hoog, S. (2009) · Medical Mycology · doi:10.1080/13693780802627440 · Cited by 67
Alastruey‐Izquierdo, A., Cuenca‐Estrella, M., Monzón, A., & Rodríguez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-06 · Cited by 58
Rodríguez, M. M., Calvo, E., Serena, C., Mariné, M., Pastor, F. J., & Guarro, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-08 · Cited by 54
Studahl, M., Backteman, T., Chryssanthou, E., Petrini, B., & Stålhammar, F. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00636.x · Cited by 53
Lackner, M., Rezusta, A., Villuendas, M. C., Palacián, M. P., Meis, J. F. G. M., & Klaassen, C. H. W. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02110.x · Cited by 53
Self-citationCombination chemotherapy for the treatment of invasive infections by Scedosporium prolificans
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., & Verweij, P. E. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00089.x · Cited by 44
Self-citationYamazaki, T., Inagaki, Y., Fujii, T., Ohwada, J., Tsukazaki, M., UMEDA, I., Kobayashi, K., Shimma, N., Page, M. G. P., & Arisawa, M. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.003 · Cited by 42
Tintelnot, K., Wagner, N., Seibold, M., de Hoog, S., & Horré, R. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01579.x · Cited by 39
Scedosporium prolificans, a multi-resistant fungus, from a U.K. AIDS patient
Hopwood, V., Evans, E. G. V., Matthews, J. J., et al. (1995) · Journal of Infection · doi:10.1016/s0163-4453(95)80011-5 · Cited by 37
Wiederhold, N. P., & Lewis, R. E. (2008) · Medical Mycology · doi:10.1080/13693780802510224 · Cited by 37
Micafungin Concentrations from Brain Tissue and Pancreatic Pseudocyst Fluid
Lat, A., Thompson, G. R., Rinaldi, M. G., Dorsey, S. A., Pennick, G. J., & Lewis, J. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01294-09 · Cited by 24
Successful Treatment of Scedosporium aurantiacum Osteomyelitis in an Immunocompetent Patient
Kooijman, C. M., Kampinga, G. A., de Hoog, S., Goudswaard, W. B., & Reijnen, M. M. P. J. (2007) · Surgical Infections · doi:10.1089/sur.2006.038 · Cited by 20
Diversity in Scedosporium dehoogii (Microascaceae): S. deficiens sp. nov.
Rainer, J., & Kaltseis, J. (2010) · Sydowia · Cited by 10
Cited by
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Tortorano, A. M., Richardson, M., Roilides, E., van Diepeningen, A., Caira, M., Munoz, P., Johnson, E., Meletiadis, J., Pana, Z.-D., Lackner, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12465 · Cited by 523
Self-citationHoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., Lackner, M., Sprute, R., Al-Hatmi, A. M. S., Bassetti, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30784-2 · Cited by 470
Self-citation
Metadata
- Authors
- Lackner, M., de Hoog, G. S., Verweij, P. E., Najafzadeh, M. J., Curfs-Breuker, I., Klaassen, C. H., & Meis, J. F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-05
- Volume
- 56
- Issue
- 5
- Pages
- 2635-2642
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2151043417
- Cited by
- 290
- References
- 44
- FWCI
- 13.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.